Yuka Group, Inc. is a holding company, which operates through its fully owned subsidiary. Its products include Testosterone Replacement Therapy, Platelet Rich Plasma Injections, PT-141 Peptide Therapy, Trimix and Quadmix Injections, and Pulse Focused Waive Therapy. The company was founded on April 2, 1991 and is headquartered in Aventura, FL.
Sector:
Non Energy Minerals
Industry:
Other Metals Or Minerals
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Yuka Group Inc market cap is $1.68M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Yuka Group Inc 52 week high is $0.07 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Yuka Group Inc 52 week low is $0.0051 as of November 18, 2026.
Yuka Group Inc stock price today is $0.0355.
Yuka Group Inc stock price yesterday was $0.0355.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Yuka Group Inc's P/E ratio is -3.62.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Yuka Group Inc P/B ratio is -2.1927.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Yuka Group Inc 50-day moving average is $0.0337.